Filing Details
- Accession Number:
- 0001179110-11-014093
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-10-05 20:35:24
- Reporting Period:
- 2011-10-03
- Filing Date:
- 2011-10-05
- Accepted Time:
- 2011-10-05 20:35:24
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
882095 | Gilead Sciences Inc | GILD | Biological Products, (No Disgnostic Substances) (2836) | 943047598 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1334682 | H Gregg Alton | Gilead Sciences, Inc. 333 Lakeside Drive Foster City CA 94404 | Evp, Corp & Med Affairs | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2011-10-03 | 7,000 | $16.01 | 37,790 | No | 4 | M | Direct | |
Common Stock | Disposition | 2011-10-03 | 7,057 | $38.50 | 30,733 | No | 4 | S | Direct | |
Common Stock | Disposition | 2011-10-03 | 943 | $37.95 | 29,790 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2011-10-03 | 7,000 | $0.00 | 7,000 | $16.01 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
13,500 | 2015-01-26 | No | 4 | M | Direct |
Footnotes
- The options have a 5 year vesting schedule. 20% of the options vested on January 26, 2006, the first anniversary of the date of the grant. The balance vested 5% every three months thereafter until fully vested on January 26, 2010. The options expire on January 26, 2015.
- Sale prices reported for the transactions reported here range from $38. to $39. Full information regarding the number of shares purchased or sold at each price will be provided to the SEC, the issuer or its shareowners upon request.